|
SPPL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.572400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.715600E-01 |
| Normal-vs-Stage2 |
1.537900E-02 |
| Normal-vs-Stage3 |
3.077500E-02 |
| Normal-vs-Stage4 |
2.845600E-01 |
| Stage1-vs-Stage2 |
3.100300E-03 |
| Stage1-vs-Stage3 |
3.981300E-03 |
| Stage1-vs-Stage4 |
1.475570E-01 |
| Stage2-vs-Stage3 |
3.949400E-01 |
| Stage2-vs-Stage4 |
1.782590E-01 |
| Stage3-vs-Stage4 |
4.133400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.067400E-01 |
| Normal-vs-AfricanAmerican |
9.965800E-01 |
| Normal-vs-Asian |
2.935600E-01 |
| Caucasian-vs-AfricanAmerican |
2.661800E-01 |
| Caucasian-vs-Asian |
9.027200E-01 |
| AfricanAmerican-vs-Asian |
3.629800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.245980E-01 |
| Normal-vs-Female |
8.198000E-01 |
| Male-vs-Female |
5.480400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.806800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.896200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.379160E-01 |
| Normal-vs-Age(81-100Yrs) |
9.360100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.721200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.154400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.882300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.328400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.327840E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.166200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.537020E-01 |
| Normal-vs-Grade 2 |
8.715800E-01 |
| Normal-vs-Grade 3 |
2.858400E-02 |
| Normal-vs-Grade 4 |
3.376200E-02 |
| Grade 1-vs-Grade 2 |
1.758790E-01 |
| Grade 1-vs-Grade 3 |
8.863600E-03 |
| Grade 1-vs-Grade 4 |
1.068290E-02 |
| Grade 2-vs-Grade 3 |
1.040760E-03 |
| Grade 2-vs-Grade 4 |
5.461300E-03 |
| Grade 3-vs-Grade 4 |
6.218200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.212200E-01 |
| Normal-vs-ccB subtype |
5.533600E-01 |
| ccA subtype-vs-ccB subtype |
7.327400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.018400E-01 |
| Normal-vs-N1 |
9.475800E-01 |
| N0-vs-N1 |
6.515200E-01 |
|
|
